Position in DXCM
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,250,083
-$169,197 QoQ
Shares Held
18,561
-17.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#447
of 966 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Intesa Sanpaolo S.p.A. holds $49,678,731 across 7 Medical Devices names. DXCM ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
445,305 | $19,005,617 | |
| 2 | SYK |
Stryker Corp
|
43,706 | $13,760,397 | |
| 3 | MDT |
Medtronic plc
|
114,277 | $8,939,889 | |
| 4 | ABT |
Abbott Laboratories
|
47,379 | $4,299,170 | |
| 5 | EW |
Edwards Lifesciences Corp
|
26,790 | $2,423,423 | |
| 6 | DXCM |
Dexcom Inc
This page
|
18,561 | $1,250,083 | |
| 7 | PODD |
Insulet Corp
|
1 | $152 |
All Filings in DXCM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,250,083 | 18,561 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $1,419,280 | 22,600 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,499,962 | 22,600 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||